Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor

Journal of Medicinal Chemistry
Delia PretiKatia Varani

Abstract

Stimulation of A2A adenosine receptors (AR) promotes anti-inflammatory responses in animal models of allergic rhinitis, asthma, chronic obstructive pulmonary disease, and rheumatic diseases. Herein we describe the results of a research program aimed at identifying potent and selective agonists of the A2AAR as potential anti-inflammatory agents. The recent crystallographic analysis of A2AAR agonists and antagonists in complex with the receptor provided key information on the structural determinants leading to receptor activation or blocking. In light of this, we designed a new series of 2-((4-aryl(alkyl)piperazin-1-yl)alkylamino)-5'-N-ethylcarboxamidoadenosines with high A2AAR affinity, activation potency and selectivity obtained by merging distinctive structural elements of known agonists and antagonists of the investigated target. Docking-based SAR optimization allowed us to identify compound 42 as one of the most potent and selective A2A agonist discovered so far (Ki hA2AAR = 4.8 nM, EC50 hA2AAR = 4.9 nM, Ki hA1AR > 10 000 nM, Ki hA3AR = 1487 nM, EC50 hA2BAR > 10 000 nM).

References

Sep 1, 1980·Analytical Biochemistry·P J Munson, D Rodbard
Oct 31, 2003·Journal of Medicinal Chemistry·Soo-Kyung KimKenneth A Jacobson
Jul 13, 2004·Bioorganic & Medicinal Chemistry·Hee Kyung JungAe Nim Pae
Sep 3, 2004·Bioorganic & Medicinal Chemistry Letters·Chi B VuRussell C Petter
Jul 19, 2005·Expert Opinion on Investigational Drugs·Courtney M LappasJoel Linden
Oct 14, 2005·Journal of Computational Chemistry·James C PhillipsKlaus Schulten
Sep 19, 2007·Expert Opinion on Emerging Drugs·Zhan-Guo Gao, Kenneth A Jacobson
Sep 25, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Katia VaraniPier Andrea Borea
Dec 17, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Katia VaraniPier Andrea Borea
Dec 25, 2009·Bioorganic & Medicinal Chemistry Letters·David BeattieHannah Woodward
Feb 16, 2010·Experimental Cell Research·Bertil B Fredholm
May 14, 2010·Journal of the American Chemical Society·Francesco ColizziAndrea Cavalli
Aug 10, 2010·Autoimmunity Reviews·Katia VaraniPier Andrea Borea
Dec 28, 2010·Biochimica Et Biophysica Acta·Christa E Müller, Kenneth A Jacobson
Mar 12, 2011·Science·Fei XuRaymond C Stevens
Aug 4, 2011·Pharmacology & Therapeutics·Marie Therese ArmenteroRafael Franco
Oct 11, 2011·Journal of the American Chemical Society·Peter SchmidtkeXavier Barril
Mar 29, 2013·Nature Reviews. Drug Discovery·Jiang-Fan ChenBertil B Fredholm
Jun 15, 2013·Pharmacology & Therapeutics·John P HeadrickJason N Peart
Oct 30, 2013·Journal of Medicinal Chemistry·Manuel de Lera RuizJunying Zheng
Sep 2, 2014·Current Medicinal Chemistry·G Yuan, G B Jones
Apr 1, 2012·Molecular Informatics·Agostino Bruno, Gabriele Costantino

❮ Previous
Next ❯

Citations

Mar 14, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kelton L B Dos SantosCleydson B R Santos
Jul 25, 2019·Current Pharmaceutical Design·Omar H A Al-AttraqchiNoor H A Al-Attraqchi
Nov 8, 2017·Current Medicinal Chemistry·Agostino BrunoMarco Radi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.